Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    Aminopeptidase N/CD13 Antibody (122), mFluor Violet 500 SE, Novus Biologicals™
 
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rabbit Monoclonal Antibody
Supplier: Novus Biologicals NBP289242MFV500
Description
Aminopeptidase N/CD13 Monoclonal antibody specifically detects Aminopeptidase N/CD13 in Human samples. It is validated for Western Blot, ELISA, Immunohistochemistry (Paraffin)Specifications
| Aminopeptidase N/CD13 | |
| Monoclonal | |
| mFluor Violet 500 SE | |
| 50mM Sodium Borate | |
| Rabbit | |
| Protein A purified | |
| RUO | |
| Primary | |
| Human | |
| Purified | 
| Western Blot, ELISA, Immunohistochemistry (Paraffin) | |
| 122 | |
| Western Blot, ELISA, Immunohistochemistry-Paraffin | |
| alanyl (membrane) aminopeptidase, Alanyl aminopeptidase, Aminopeptidase M, aminopeptidase N, AP-M, AP-N, CD13 antigen, CD13APN, EC 3.4.11, EC 3.4.11.2, gp150, LAP1, Microsomal aminopeptidase, Myeloid plasma membrane glycoprotein CD13, P150, PEPNhAPN | |
| This antibody was obtained from a rabbit immunized with purified, recombinant Human Aminopeptidase N/CD13 (Accession#: NP_001141.2; Lys 69-Lys 967, 603 Met/Ile). | |
| 0.1 mL | |
| Angiogenesis, Cellular Markers, Hematopoietic Stem Cell Markers, Immunology, Mesenchymal Stem Cell Markers, Myeloid derived Suppressor Cell, Stem Cell Markers | |
| 290 | |
| Store at 4C in the dark. | |
| IgG | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction
            